Structural Formula (Att00 0001 01)
Attruby Tablet, Film Coated
Product Images NDC 82228-712
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Attruby (NDC 82228-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bridgebio Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Att00 0001 02)
Figure 2 (Att00 0001 03)
This text appears to be showing a comparison of LS Mean Change from Baseline Scores for two different groups - ATIRUBY and Placebo, over a period of 18 months. The numbers represent the scores for each month, with a percentage change indicated for ATIRUBY.*
Figure 3 (Att00 0001 04)
The provided text seems to be a table showing data related to a medical study or clinical trial. It includes information about the number of subjects remaining at risk over time since randomization for two groups – "ATTRUBY" and "Placebo." The table displays the cumulative events at various time points in months, ranging from 0 to 30 months. This data could be used to analyze the progression of an experiment or treatment in a research setting.*
Figure 4 (Att00 0001 05)
Principal Display Panel – 356 mg Carton Label (Att00 0001 06)
Description: A medication labeled as "Att ruby bridgebio" containing 356 mg acoramidis per tablet. The recommended dosage is two 356 mg tablets two times a day. The medication comes in blister cards with 28 tablets per card, totaling 112 tablets. Store at 20°C to 25°C and protect from moisture. Manufactured in Germany by BridgeBio Pharma, Inc. For more information, visit Att ruby.com.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
